BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

Source: 
Reuters
snippet: 

Germany's BioNTech (22UAy.DE) said on Monday that it signed a deal with Chinese biotech company DualityBio to co-develop and commercialize two cancer antibody drug candidates.